Storebrand Asset Management’s AbbVie ABBV Stock Holding History

Storebrand Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271M	Buy	1,078,470 +36,523	+4%	+$7.86M	0.67%	24
2026 Q1	$227M	Sell	1,041,947 -10,653	-1%	-$2.36M	0.65%	20
2025 Q4	$241M	Buy	1,052,600 +17,641	+2%	+$4.02M	0.65%	19
2025 Q3	$240M	Buy	1,034,959 +21,429	+2%	+$4.36M	0.63%	21
2025 Q2	$188M	Buy	1,013,530 +7,884	+0.8%	+$1.47M	0.55%	24
2025 Q1	$211M	Sell	1,005,646 -40,041	-4%	-$7.78M	0.69%	22
2024 Q4	$186M	Buy	1,045,687 +48,330	+5%	+$8.89M	0.56%	28
2024 Q3	$197M	Buy	997,357 +24,208	+2%	+$4.52M	0.62%	22
2024 Q2	$167M	Sell	973,149 -26,889	-3%	-$4.45M	0.55%	30
2024 Q1	$182M	Buy	1,000,038 +8,390	+0.8%	+$1.45M	0.62%	27
2023 Q4	$154M	Buy	991,648 +68,646	+7%	+$10M	0.56%	33
2023 Q3	$138M	Sell	923,002 -3,357	-0.4%	-$493K	0.66%	23
2023 Q2	$125M	Buy	926,359 +24,946	+3%	+$3.66M	0.57%	31
2023 Q1	$144M	Sell	901,413 -50,471	-5%	-$7.72M	0.73%	18
2022 Q4	$154M	Sell	951,884 -11,624	-1%	-$1.78M	0.85%	16
2022 Q3	$129M	Sell	963,508 -19,483	-2%	-$2.8M	0.78%	18
2022 Q2	$151M	Buy	982,991 +97,042	+11%	+$14.8M	0.85%	14
2022 Q1	$144M	Buy	885,949 +48,859	+6%	+$7.1M	0.68%	21
2021 Q4	$113M	Buy	837,090 +12,155	+1%	+$1.44M	0.5%	36
2021 Q3	$89M	Buy	824,935 +1,999	+0.2%	+$228K	0.44%	45
2021 Q2	$92.7M	Buy	822,936 +20,405	+3%	+$2.3M	0.45%	40
2021 Q1	$86.8M	Buy	802,531 +45,345	+6%	+$4.85M	0.46%	42
2020 Q4	$81.1M	Buy	757,186 +27,695	+4%	+$2.66M	0.48%	42
2020 Q3	$63.9M	Buy	729,491 +59,400	+9%	+$5.59M	0.46%	48
2020 Q2	$65.8M	Buy	670,091 +152,564	+29%	+$13.4M	0.54%	36
2020 Q1	$39.4M	Buy	+517,527	New	+$44.1M	0.41%	55

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Storebrand Asset Management's ABBV Position: Q2 2026 in Review

Storebrand Asset Management increased its AbbVie (ABBV) stake by 3.5% in Q2 2026, buying an estimated $7.86M and bringing the position to 1,078,470 shares worth $271M. The position accounts for 0.67% of the portfolio, ranked #24.

Storebrand Asset Management first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Storebrand Asset Management held 1,078,470 shares of AbbVie worth $271M as of Q2 2026.
Storebrand Asset Management bought 36,523 AbbVie shares in Q2 2026, an estimated $7.86M.
AbbVie made up 0.67% of Storebrand Asset Management's portfolio in Q2 2026, its #24 holding.
Storebrand Asset Management first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.